an 80-year-old man developed nightmares while using citalopram for mild depression. during the first two weeks of treatment with citalopram (10 mg daily), he didn’t experience any adverse reactions. after two weeks, he developed nightmaresand vivid dreams that were repeated every night and awakened him in midnight. although the signs of depression were relatively disappeared, the patient was an...

N have been defined as “very disturbing dreams involving any unpleasant emotion” (1). Although often considered a childhood condition, a substantial percentage of participants in nonclinical adult samples have reported nightmares. For example, the number of nonclinical, adult participants who have reported experiencing nightmares at least once a month ranged from 8.3% (2) to 52.2% (3). Nightmar...

BACKGROUND There is growing evidence of an association of a number of subjective and objective sleep parameters (especially nightmares) and elevated suicidal risk in different clinical populations as well as in the general populations. SUBJECTS AND METHODS This is a cross-sectional naturalistic study of 52 inpatients (28 females and 24 males, aged from 24 to 75 years) meeting criteria for a c...

Prazosin is recommended for treatment of Posttraumatic Stress Disorder (PTSD)-associated nightmares. Level A. Image Rehearsal Therapy (IRT) is recommended for treatment of nightmare disorder. Level A. Systematic Desensitization and Progressive Deep Muscle Relaxation training are suggested for treatment of idiopathic nightmares. Level B. Venlafaxine is not suggested for treatment of PTSD-associa...

CHRONIC NIGHTMARES ARE A COMMON CONDITION AFFLICTING AT LEAST 4% OF THE ADULT POPULATION AND A HIGHER, ALBEIT UNDETERMINED, PROPORTION of children and adolescents.1 Nightmares cause or exacerbate insomnia2,3 and psychiatric distress,4-6 as well as impair quality of life.7 Several techniques have been fully developed or explored to treat nightmares, including imagery rehearsal therapy,8-14 lucid...

The present study investigated the prevalence and heritability of nightmares and their comorbidity with psychopathology in a sample (N = 1,318) of children, adolescents, and child and adolescent twins ranging in age from 4 to 17 years old. The prevalence of terrible nightmares was estimated to be 6.4%, which is similar to previous studies. There were marginal gender differences in this rate (7....

Pharmacologic treatment of patients with post-traumatic stress disorder often involves antidepressant drugs. Combat nightmares often persist. The addition of cyproheptadine, in a median dose of 16-24 mg orally at night, controls the nightmares.